Skip to main content
Journal of Big Data
Fig. 8 | Journal of Big Data

Fig. 8

From: Liquid biopsy-based identification of prognostic and immunotherapeutically relevant gene signatures in lower grade glioma

Fig. 8

Clinical and mutational characteristics of RRG-related RiskScore. a Differences in RRG-related RiskScore between astrocytomas, oligoastrocytomas and oligodendrogliomas. The differences between every two groups were compared through the Kruskal–Wallis test. b Differences in RRG-related RiskScore between grade II and grade III tumor. The difference was compared through the Kruskal–Wallis test. c Differences in RRG-related RiskScore between subtype 1, subtype 2 and subtype 3. The differences between every two groups were compared through the Kruskal–Wallis test. d, e Differences in TMB (d) and neoantigen counts (e) between high- and low-RiskScore groups. The difference was compared through the Kruskal–Wallis test. f The top 30 frequently mutated genes in high- and low-RiskScore groups. g Differences in RiskScore between IDH1-mutant and IDH1-wild-type groups. The difference was compared through the Kruskal–Wallis test. **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page